Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Street Still Underestimating J&J’s Pipeline: Citi
Barron's
Thursday, August 4, 2011 - 9:17am
tags:
JNJ, pipelines, Zytiga, Xarelto, Incivo
Ignore Pfizer's Financials for Now
Motley Fool
Thursday, August 4, 2011 - 9:16am
tags:
Pfizer, earnings
Pfizer plans OTC version of Lipitor: WSJ
Marketwatch
Thursday, August 4, 2011 - 9:15am
tags:
Pfizer, OTC, Lipitor
One doctor’s experience with drug company lunches
Fredericksburg.com, VA
Wednesday, August 3, 2011 - 12:01pm
tags:
physicians, Eli Lilly
Widely used PTSD drug fails test in combat veterans
CNBC
Wednesday, August 3, 2011 - 11:13am
tags:
Risperidone, PTSD, post traumatic stress disorder, Risperdal, Janssen Pharmaceuticals
Vectura gets new U.S. partner for copy of lung drug
Reuters
Wednesday, August 3, 2011 - 11:10am
tags:
Vectura, GSK, generics, Advair, VR315
3 Undervalued Biotechs With Buyout Potential
Seeking Alpha
Wednesday, August 3, 2011 - 11:08am
tags:
Biogen Idec, Abbott Laboratories, Elan, Adeona, Acorda Therapeutics, M&A
Does Vertex Pharmaceuticals Deserve a Higher Valuation?
Seeking Alpha
Wednesday, August 3, 2011 - 11:05am
tags:
Vertex Pharmaceuticals
Allergan Profit Rises on Sales of Botox Wrinkle Treatment, Breast Implants
Bloomberg
Wednesday, August 3, 2011 - 11:03am
tags:
Allergan, Botox, earnings
Six Pharma Rebels
Forbes
Wednesday, August 3, 2011 - 10:08am
tags:
pharma execs
MSMB Capital Offers $378 Million to Take Over Anemia-Drug Maker Amag
Bloomberg
Wednesday, August 3, 2011 - 9:41am
tags:
anemia, M&A, MSMB Capital, Amag Pharmaceuticals
MAP Pharmaceuticals gets $20M payment for FDA filing
Bizjournals.com
Wednesday, August 3, 2011 - 9:40am
tags:
FDA, MAP Pharmaceuticals, Levadex, migraines, Allergan
Eisai Declines Most in Four Months on Aricept Sales Prospects
Bloomberg
Wednesday, August 3, 2011 - 9:38am
tags:
Aricept, Eisai, Alzheimer's disease
Is Air Leaking Out Of The Genomics Bubble?
Forbes
Tuesday, August 2, 2011 - 8:23pm
tags:
genomics, Complete Genomics, Life Technologies, Illumina, Affymetrix, Pacific Biosciences, Caliper Life Sciences
New Nycomed US chief aims to grow by M&A
Fierce Pharma
Tuesday, August 2, 2011 - 8:21pm
tags:
M&A, Nycomed, Pharma CEOs, Takeda, Brian Markison
Merck says employee reductions will begin 'later this year'
Newark Star-Ledger, NJ
Tuesday, August 2, 2011 - 8:20pm
tags:
Merck, layoffs
Cephalon 2Q profit rises on better Treanda sales
Yahoo/AP
Tuesday, August 2, 2011 - 8:19pm
tags:
Cephalon, earnings
What Are The Signals Genetics Testing Firm Illumina Is Sending?
Investors.com
Tuesday, August 2, 2011 - 4:27pm
tags:
genetic testing, Illumina
Impax Labs 2nd-quarter profit sinks 60 percent
Yahoo/AP
Tuesday, August 2, 2011 - 4:14pm
tags:
earnings, Impax Labs
The Race: FDA Approval or Buyout?
Motley Fool
Tuesday, August 2, 2011 - 4:12pm
tags:
FDA, Amarin, AMR101

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.